Women’s Health Strategy: Endometriosis and Fibroids

Karin Smyth Excerpts

Thursday 5th March 2026 Commons Chamber

[The Minister for Secondary Care (Karin Smyth)]

I congratulate my hon. Friend the Member for Erith and Thamesmead (Ms Oppong-Asare) on securing this important debate. Baroness Merron, who leads on this work for the Department, and I are grateful to my hon. Friend for the conversations that she has been leading; for putting the spotlight on endometriosis, as well as on the renewed women’s health strategy; and for giving me the opportunity to set out what the Government are doing this Endometriosis Action Month.

As my hon. Friend has said, for far too long, women with gynaecological conditions including endometriosis and fibroids have been failed. We acknowledge the impact that that has on all aspects of their lives. This Government’s message to women is clear: you do not have to put up with that any more.

I am pleased to hear that my hon. Friend will be hosting a screening of the short film “This Is Endometriosis”, which is about the harrowing experience of a woman seeking care for her endometriosis symptoms. I hope to be able to get along to that screening when it happens, and I encourage others to do so, too.

This Government inherited a broken NHS system that still does not understand the needs of many women and was not designed with women in mind. We are committed to changing that, and to ensuring that women are listened to and get the healthcare that they need, when they need it. Improving awareness of endometriosis, fibroids and other women’s health conditions is a vital first step in meeting our commitment to end this neglect of women’s health and reduce the stigma attached to it. My hon. Friend is doing her part through this debate.

The General Medical Council has begun work to improve women’s health representation in the curricula used to train healthcare professionals. Since last year, students graduating from UK medical schools have been required to pass the medical licensing assessment, which encourages a better understanding of common women’s health problems among all doctors as they start their career in the UK. This assessment includes topics to do with women’s health, including endometriosis and fibroids. Women’s health is included in the Royal College of General Practitioners’ curriculum for trainee GPs and its women’s health library, which brings together educational resources and guidelines on women’s health. In November 2024, the National Institute for Health and Care Excellence updated its guidelines on endometriosis to make recommendations for healthcare professionals on referral and investigations for women for whom that is suspected to be the diagnosis.

Taken together, these actions will improve the standard of care that women receive. It is encouraging to see not just the NHS but all our partners and arm’s length bodies taking action to raise awareness and improve training. This work has to be ongoing across Government. It is shocking, perhaps, that this started only fairly recently, but like my hon. Friend, I pay tribute to many hon. Members across the House who have led an awful lot of work to raise awareness of this issue in the last few Parliaments, and I think that work is starting to bear fruit. Last July, the Department for Education published revised statutory guidance that sets out in black and white that secondary schools should cover menstrual and gynaecological health, covering things like heavy bleeding and when to seek help from professionals.

Women often spend years being dismissed, misdiagnosed or simply not listened to. This was reflected in Endometriosis UK’s recent report, which my hon. Friend has made reference to. We are clear that this is unacceptable, and that women should not have to put up with it any more. We have introduced Jess’s rule, which requires GPs to rethink diagnoses for their patients. We are also rolling out Martha’s rule, which will give in-patients in acute hospitals in England the ability to initiate a rapid review of their case by someone outside their immediate care team. These rules will help to ensure that women are listened to by their doctors, and that their concerns are not dismissed.

Early diagnosis is key, and that is why we continue to roll out community diagnostic centres across the country for women on gynaecological pathways. As of last month, 106 community diagnostic centres across the country offer an out-of-hours service 12 hours a day, seven days a week, meaning that patients can access vital diagnostic tests around busy working lives.

In September, we announced NHS Online, a new online hospital, to give women on certain pathways the choice of getting the specialist care that they need from their home. This will mean that wherever women live in this country, they can access the very best gynaecological care. Earlier this year, we announced that menstrual problems, which may be a sign of endometriosis and fibroids, will be among the first nine conditions available for referral from 2027. The detail is being worked through ahead of the launch next year.

Our revolutionary online hospital will help reduce patient waiting times, and deliver the equivalent of up to 8.5 million appointments and assessments in its first three years. That is four times more than an average trust, and it will give women choice and control over their care. Finally, this Government are committed to encouraging integrated care boards to further expand women’s healthcare at neighbourhood level, and to support ICBs in learning from women’s health hub pilots, so that they can improve services for women, as well as for the rest of the population.

Women can be impacted by a range of health conditions at the same time, including those that only affect women; those that affect women differently from, or more severely than, men; and those that affect different groups differently, such as fibroids. As my hon. Friend said, black women are disproportionately affected, and often face barriers to timely and compassionate care. This is also the case for ethnically diverse women with endometriosis, as highlighted in the Endometriosis UK report.

We are not complacent about these inequalities. We are committed to building a fairer Britain to ensure that people can live well for longer and spend less time in ill health. Our 10-year health plan will focus on shifting care from hospital to communities, and on how neighbourhood delivery will help address gaps in provision and long waiting times, specifically for those from deprived areas in constituencies like mine, and women from ethnic minority backgrounds.

Let me turn to the point about research made by the hon. Member for Didcot and Wantage (Olly Glover). The Department, through the National Institute for Health and Care Research, has commissioned several studies focused on endometriosis diagnosis, treatment and patient experience. The NIHR is funding seven active research awards, with investment totalling £7.8 million. That includes a new £2.3 million award for research starting in March 2026 on the effectiveness of pain management for endometriosis.

As my hon. Friend the Member for Erith and Thamesmead has said, we know that services are not serving women as they need to right now, but there are some helpful signs that that is starting to change. Training and awareness are a key part of that. We need to keep highlighting the differences as women present for care. We will listen to women, and I look forward to working with my hon. Friend and others on developing and implementing a renewed women’s health strategy over the coming months.

Question put and agreed to.